Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Luffy

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Thyroid : Official Journal of the American Thyroid Association|February 13, 2026
Euthyroidism and Long-Term Remission of Graves' Hyperthyroidism Following Treatment With an FcRn Blocker: A Case ReportGeorge J Kahaly, Jan Wolf, Maximilian Luffy, et al.
The Journal of Clinical Endocrinology and Metabolism|July 19, 2024
US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid DiseaseMark A Lupo, Paul D Olivo, Maximilian Luffy, et al.
Frontiers in Endocrinology|November 13, 2024
A novel bioassay for thyroid-blocking immunoglobulinsAugustine George, Johannes Lotz, Maximilian Luffy, et al.
Journal of Endocrinological Investigation|August 29, 2025
Bibliometrics in thyroid eye diseaseYuanPing Hai, QinTao Ma, Anqi Huang, et al.
European Thyroid Journal|October 6, 2025
Graves' disease in ectopic thyroid tissue: a scoping review and a case studyAnnick Van den Bruel, Pieter Drieskens, Helena Van Haecke, et al.
Frontiers in Immunology|December 26, 2024
Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cellsMaximilian Luffy, Anna-Lena Ganz, Stefanie Wagner, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2025
Secukinumab in Moderate-to-Severe Graves' Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter StudyJan Wolf, Katrin Lorenz, Ahmed E Othman, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Thyroid : Official Journal of the American Thyroid Association|February 13, 2026
Euthyroidism and Long-Term Remission of Graves' Hyperthyroidism Following Treatment With an FcRn Blocker: A Case ReportGeorge J Kahaly, Jan Wolf, Maximilian Luffy, et al.
The Journal of Clinical Endocrinology and Metabolism|July 19, 2024
US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid DiseaseMark A Lupo, Paul D Olivo, Maximilian Luffy, et al.
Frontiers in Endocrinology|November 13, 2024
A novel bioassay for thyroid-blocking immunoglobulinsAugustine George, Johannes Lotz, Maximilian Luffy, et al.
Journal of Endocrinological Investigation|August 29, 2025
Bibliometrics in thyroid eye diseaseYuanPing Hai, QinTao Ma, Anqi Huang, et al.
European Thyroid Journal|October 6, 2025
Graves' disease in ectopic thyroid tissue: a scoping review and a case studyAnnick Van den Bruel, Pieter Drieskens, Helena Van Haecke, et al.
Frontiers in Immunology|December 26, 2024
Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cellsMaximilian Luffy, Anna-Lena Ganz, Stefanie Wagner, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2025
Secukinumab in Moderate-to-Severe Graves' Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter StudyJan Wolf, Katrin Lorenz, Ahmed E Othman, et al.
Pageof 1